Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000465473 | SCV000551830 | benign | Retinoblastoma | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001013560 | SCV001174165 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001013560 | SCV002530811 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-02-16 | criteria provided, single submitter | curation | |
Gene |
RCV003227760 | SCV003924770 | uncertain significance | not provided | 2022-11-09 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23516486, Dayalan_2006_Review, 24686850, 35434667) |
All of Us Research Program, |
RCV000465473 | SCV004844706 | likely benign | Retinoblastoma | 2023-12-18 | criteria provided, single submitter | clinical testing |